Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-003695
Filing Date
2017-01-31
Accepted
2017-01-31 14:56:17
Documents
2
Period of Report
2017-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6272
2 poa_philipastleysparke.htm EX-24.1 8238
  Complete submission text file 0001140361-17-003695.txt   15854
Mailing Address C/O BIOVEX GROUP, INC. 34 COMMERCE WAY WOBURN MA 10801
Business Address
Astley-Sparke Philip (Reporting) CIK: 0001376491 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 17560717

Mailing Address MEIBERGDREFF 61 AMSTERDAM P7 1005 BA
Business Address MEIBERGDREFF 61 AMSTERDAM P7 1005 BA 31-20-5667394
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations